CDEK
← All organizations

Acrivon Therapeutics

For profit

Also known as: Acrivon Therapeutics

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Aug 29, 2022

Last known activity

Oct 8, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (3 distinct, 3 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Recent trials (3)

Details

Founded
Boston, MA, US
Last known activity
Oct 8, 2024